Hepatocyte DACH1 Is Increased in Obesity via Nuclear Exclusion of HDAC4 and Promotes Hepatic Insulin Resistance
Defective insulin signaling in hepatocytes is a key factor in type 2 diabetes. In obesity, activation of calcium/calmodulin-dependent protein kinase II (CaMKII) in hepatocytes suppresses ATF6, which triggers a PERK-ATF4-TRB3 pathway that disrupts insulin signaling. Elucidating how CaMKII suppresses...
Main Authors: | Lale Ozcan, Devram S. Ghorpade, Ze Zheng, Jane Cristina de Souza, Ke Chen, Marc Bessler, Melissa Bagloo, Beth Schrope, Richard Pestell, Ira Tabas |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716305599 |
Similar Items
-
Suppression of Adaptive Immune Cell Activation Does Not Alter Innate Immune Adipose Inflammation or Insulin Resistance in Obesity.
by: Manikandan Subramanian, et al.
Published: (2015-01-01) -
DACH1 suppresses breast cancer as a negative regulator of CD44
by: Hanxiao Xu, et al.
Published: (2017-06-01) -
DACH1 antagonizes CXCL8 to repress tumorigenesis of lung adenocarcinoma and improve prognosis
by: Qian Liu, et al.
Published: (2018-04-01) -
Role of Dach1 revealed using a novel inner ear-specific Dach1-knockdown mouse model
by: Toru Miwa, et al.
Published: (2019-08-01) -
Welcome to the 7th DACH+ Conference on Energy Informatics
by: Sebastian Lehnhoff
Published: (2018-11-01)